Mark Howard Snyder - Jun 12, 2024 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF LEGAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Jun 12, 2024
Transactions value $
$0
Form type
4
Date filed
6/14/2024, 04:17 PM
Previous filing
Feb 27, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Award $0 +20.1K $0.00 20.1K Jun 12, 2024 Common Stock 20.1K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The grant of restricted stock units reported on this Form 4 was awarded to Mr. Snyder in recognition of his contribution to the recent issuance of a European patent covering the Company's ENHANZE(R) rHuPH20 product that the Company provides to its licensees.
F2 This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.